Johnson & Johnson ( JNJ) - Key Metrics
JNJ Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | ? | ? | ? | ? |
| 2026Q1 | ? | ? | ? | ? |
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $10.11 | $2.11 | ? | ? |
| 2025Q4 | $10.11 | $2.11 | $3.01 | $2.25 |
JNJ Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | ? | ? |
| 2026Q1 | ? | ? |
| 2026Q1 | ? | ? |
| 2025Q4 | 61.71% | 24.56 |
| 2025Q4 | 61.20% | 24.63 |
JNJ Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | ? | ? |
| 2026Q1 | ? | ? |
| 2026Q1 | 0.25% | ? |
| 2025Q4 | ? | 0.63% |
| 2025Q4 | 1.09% | 0.62% |
JNJ
List: Champions
Price: $260.35
Dividend Yield: 2.04%
Forward Dividend Yield: 2.06%
Payout Ratio: 75.04%
Dividend Per Share: 5.36 USD
Earnings Per Share: 8.67 USD
P/E Ratio: 28.91
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United States
Volume: 6.9 million
Ebitda: 2.9 billionMarket Capitalization: 618.8 billion
Average Dividend Frequency: 4
Years Paying Dividends: 26
DGR3: 5.07%
DGR5: 5.32%
DGR10: 5.77%
DGR20: 7.38%